BioSolutions, Bioquote Reach Distribution Deal for UK, Ireland | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Claremont BioSolutions today announced a distribution deal with Bioquote covering the UK and Ireland.

The deal is for Claremont's products for sample preparation, DNA isolation, and protein purification and extends the Upland, Calif.-based company's reach into Europe. The first product to be marketed will be the company's Omnilyse lysis kits and PureLyse extraction kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.